Blood Cancer
Each year, roughly 10% of all cancer diagnoses in the U.S. are attributed to blood cancers. If you or your dependent age 18 and over have received a diagnosis, Carrum Health can connect you with leading cancer specialists, to ensure you have the correct diagnosis and plan of care for the best possible outcome. And if you’ve been diagnosed with multiple myeloma, you may be covered for a full range of essential services for CAR T-cell therapy.
Understanding Blood Cancers: Types and Treatments
Blood cancers affect the production and function of blood cells. Early diagnosis and advancements in treatment have improved outcomes, making awareness and understanding important for patients and their families.
Carrum Health’s coverage for CAR T-Cell therapy
The Carrum Health cancer care benefit typically covers FDA-approved therapy for multiple myeloma that has relapsed (come back) or stopped responding to treatment. Chimeric antigen receptor (CAR) T-cell therapy is a unique and innovative cancer treatment. Doctors take some of the patient’s own immune cells and transform them in a lab so that they can recognize the cancer better. These modified cells are then put back into the patient’s body through an infusion to target and destroy the cancer.
CAR T-Cell Therapy Guidebook
This guide from the Cancer Support Community offers valuable information about CAR T-Cell Therapy and how to manage its side effects for individuals with cancer and their caregivers.
Access expert
cancer care today.
Don’t wait. No matter where you are in your cancer journey, take the first step toward better care with Carrum Health. Get started today.